The Empo solution is designed to reduce the human and economic burden of diabetic foot ulcers (DFUs)

DFU stats

“DFUs lead to amputations, quality of life issues, mortality, and increased costs. Our family medicine clinicians and podiatrists do everything they can to prevent severe ulcers, but they can’t be everywhere at once, and they currently have few options for determining what’s going on with a patient’s feet outside a healthcare setting.”

Dr. Stephen A. Morgan, MD

Family Medicine Practitioner
SVP, Chief Medical Information Officer, Carilion Clinic

“DFUs lead to amputations, quality of life issues, mortality, and increased costs. Our family medicine clinicians and podiatrists do everything they can to prevent severe ulcers, but they can’t be everywhere at once, and they currently have few options for determining what’s going on with a patient’s feet outside a healthcare setting.”

Dr. Stephen A. Morgan, MD

Family Medicine Practitioner
SVP, Chief Medical Information Officer, Carilion Clinic

Empo is here to help.

Empo Health products
The Empo Solution…

Can help improve patient outcomes and save healthcare costs by enabling early non-invasive intervention.

Employs licensed nurses for monitoring and engagement.

Includes a practice-facing web app to access and monitor patient image data.

Is designed to fit into both existing reimbursement pathways and value-based care delivery models.

Is FDA-listed, HIPAA-compliant, thoroughly tested, and manufactured in the USA.

Our solution is proven.

A pre-market study in patients with history of DFU showed near-daily adherence, early identification of problems, and timely interventions by providers.

Consistent for patients

27days

median adherence per month
over six months

Actionable for providers

45%

of patients had new issues
detected for early intervention

“It’s efficient, easy to use, and there are existing codes I can use. Empo even installs the Footprint in the patient’s home so I don’t have to stock them.”

Dr. Dawn Gretz, DPM, PA

Chief of Podiatric Surgery, MedStar Harbor Hospital
Equity-holding advisor of Empo Health

“It’s efficient, easy to use, and there are existing codes I can use. Empo even installs the Footprint in the patient’s home so I don’t have to stock them.”

Dr. Dawn Gretz, DPM, PA

Chief of Podiatric Surgery, MedStar Harbor Hospital
Equity-holding advisor of Empo Health

Now Available to Veterans Affairs (VA) Providers.

Diabetic foot ulcers are a leading cause of hospitalizations for our veterans, and now Empo can help.

The Empo solution can now be ordered by VA Medical Centers and Clinics via its listings in the Federal Supply Schedule (FSS):
FSS Item #
Empo Solution Package
Description
EMPO-G-1-FIRST-12
Initial order with setup and access to the Empo solution for 12 months.
Empo® Footprint remote visual foot monitoring scale initial order, 1 patient, white-glove installation and education; 12 months of Empo® Remote Health Link portal, monitoring, and engagement.
EMPO-G-1-FIRST-4
Initial order with setup and access to the Empo solution for 4 months.
Empo® Footprint remote visual foot monitoring scale initial order, 1 patient, white-glove installation and education; 4 months of Empo® Remote Health Link portal, monitoring, and engagement.
EMPO-G-1-RENEW-12
Renewal order with access to the Empo solution for 12 months.
Empo® Footprint remote visual foot monitoring scale renewal order, 1 patient with previously-installed Footprint; 12 months of Empo® Remote Health Link portal, monitoring, and engagement.

Interested in Empo’s solution for your veteran patients?

Empo VA orders are processed through our partner Maclean Health.

Maclean Health and the SBA

Provider Testimonials

“The Empo solution is unique in that we’re able to directly visualize the feet and see if there are any problems.”

“Using the Empo solution can improve the quality of life for our diabetic patients by preventing hospitalizations, wounds and amputations.”

“With Empo Health we can prevent problems. Early detection is early intervention, which is the most important thing.”

Initial provider testimonials are from equity-holding advisors who have tested the product prior to commercialization

Want to learn more about Empo’s solution?